The LVAD market has the potential to grow by USD 962.42 million during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 12.23%.
This LVAD market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by application (destination therapy, BTD therapy, BTT therapy, and BTR therapy) and geography (North America, Europe, Asia, and ROW). The LVAD market report also offers information on several market vendors, including Abbott Laboratories, Abiomed Inc., Berlin Heart GmbH, CorWave SA, Jarvik Heart Inc., LivaNova Plc, Medtronic Plc, Sun Medical Technology Research Institute Co. Ltd., Terumo Corp., and Transonic Systems Inc. among others.
What will the LVAD Market Size be in 2021?
Browse TOC and LoE with selected illustrations and example pages of LVAD Market
LVAD Market: Key Drivers and Trends
The increasing prevalence of heart failure is notably driving the LVAD market growth, although factors such as complexities related to regulatory compliance and associated LVADs may impede market growth. To unlock information on the key market drivers and the COVID-19 pandemic impact on the LVAD market industry get your FREE report sample now.
|
|
This LVAD market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. Get detailed insights on the trends and challenges, which will help companies evaluate and develop growth strategies.
Who are the Major LVAD Market Vendors?
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
- Abbott Laboratories
- Abiomed Inc.
- Berlin Heart GmbH
- CorWave SA
- Jarvik Heart Inc.
- LivaNova Plc
- Medtronic Plc
- Sun Medical Technology Research Institute Co. Ltd.
- Terumo Corp.
- Transonic Systems Inc.
The LVAD market is concentrated and the vendors are deploying growth strategies such as focusing on mergers and acquisitions (M&A) to compete in the market. Click here to uncover other successful business strategies deployed by the vendors.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Download a free sample of the LVAD market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Which are the Key Regions for LVAD Market?
For more insights on the market share of various regions Request for a FREE sample now!
46% of the market’s growth will originate from North America during the forecast period. The US is the key market for LVAD market in North America. Market growth in this region will be slower than the growth of the market in Europe and Asia. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report.
What are the Revenue-generating Application Segments in the LVAD Market?
To gain further insights on the market contribution of various segments Request for a FREE sample
Destination therapy usually refers to the use of an LVAD or mechanical circulatory support to keep the existing heart going, not just until a heart transplant can be done but for the rest of the patient's life. It is, therefore, a course of treatment for patients with severe heart failure in whom a heart transplant is nearly impossible. Destination therapy provides the possibility of extending the lives of such patients and improving their quality of life.
Fetch actionable market insights on post COVID-19 impact on each segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the LVAD market size.
What are the Key Factors Covered in this LVAD Market Report?
- CAGR of the market during the forecast period 2021-2025
- Detailed information on factors that will drive LVAD market growth during the next five years
- Precise estimation of the LVAD market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the LVAD market industry across North America, Europe, Asia, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of LVAD market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch
|
LVAD Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2020 |
|
Forecast period |
2021-2025 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 12% |
|
Market growth 2021-2025 |
$ 962.42 million |
|
Market structure |
Concentrated |
|
YoY growth (%) |
5.51 |
|
Regional analysis |
North America, Europe, Asia, and ROW |
|
Performing market contribution |
North America at 46% |
|
Key consumer countries |
US, Germany, France, UK, and Japan |
|
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
|
Companies profiled |
Abbott Laboratories, Abiomed Inc., Berlin Heart GmbH, CorWave SA, Jarvik Heart Inc., LivaNova Plc, Medtronic Plc, Sun Medical Technology Research Institute Co. Ltd., Terumo Corp., and Transonic Systems Inc. |
|
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |